CBUF:XETRA:XETRA-iShares MSCI World Health Care Sector ESG UCITS ETF USD Inc (EUR)

ETF | Others |

Last Closing

USD 6.766

Change

0.00 (0.00)%

Market Cap

USD 1.13B

Volume

0.05M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-16 )

ETFs Containing CBUF:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.52% 29% F 35% F
Dividend Return 0.63% 7% C- 7% C-
Total Return 3.14% 29% F 35% F
Trailing 12 Months  
Capital Gain 7.64% 35% F 40% F
Dividend Return 1.17% 15% F 15% F
Total Return 8.81% 37% F 41% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 7.88% 59% D- 58% F
Dividend Return 7.99% 59% D- 57% F
Total Return 0.10% 26% F 15% F
Risk Return Profile  
Volatility (Standard Deviation) 8.22% 69% C- 76% C+
Risk Adjusted Return 97.17% 92% A 93% A
Market Capitalization 1.13B 80% B- 70% C-

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.